BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16884969)

  • 41. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin transporter, 5-HT1A receptor, and behavior in DBA/2J mice in comparison with four inbred mouse strains.
    Popova NK; Naumenko VS; Tibeikina MA; Kulikov AV
    J Neurosci Res; 2009 Dec; 87(16):3649-57. PubMed ID: 19533737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells.
    Cheng B; Zhao S; Luo J; Sprague E; Bonewald LF; Jiang JX
    J Bone Miner Res; 2001 Feb; 16(2):249-59. PubMed ID: 11204425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of placental serotonin transporter and 5-HT 2A receptor in normal and gestational diabetes mellitus pregnancies.
    Viau M; Lafond J; Vaillancourt C
    Reprod Biomed Online; 2009 Aug; 19(2):207-15. PubMed ID: 19712556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonally-regulated expression of voltage-operated Ca(2+) channels in osteocytic (MLO-Y4) cells.
    Gu Y; Preston MR; Magnay J; El Haj AJ; Publicover SJ
    Biochem Biophys Res Commun; 2001 Mar; 282(2):536-42. PubMed ID: 11401493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary cilia mediate parathyroid hormone receptor type 1 osteogenic actions in osteocytes and osteoblasts via Gli activation.
    Martín-Guerrero E; Tirado-Cabrera I; Buendía I; Alonso V; Gortázar AR; Ardura JA
    J Cell Physiol; 2020 Oct; 235(10):7356-7369. PubMed ID: 32039485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors.
    Mannoury la Cour C; Hanoun N; Melfort M; Hen R; Lesch KP; Hamon M; Lanfumey L
    J Neurochem; 2004 May; 89(4):886-96. PubMed ID: 15140188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.
    Derangeon M; Bozon V; Defamie N; Peineau N; Bourmeyster N; Sarrouilhe D; Argibay JA; Hervé JC
    J Mol Cell Cardiol; 2010 Jan; 48(1):220-9. PubMed ID: 19615378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonergic changes produced by repeated exposure to forced swimming: correlation with behavior.
    Shishkina GT; Kalinina TS; Dygalo NN
    Ann N Y Acad Sci; 2008 Dec; 1148():148-53. PubMed ID: 19120103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5.
    Rosser J; Bonewald LF
    Methods Mol Biol; 2012; 816():67-81. PubMed ID: 22130923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.
    Sato H; Skelin I; Diksic M
    Brain Res; 2010 Jul; 1345():28-44. PubMed ID: 20501324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration.
    Huggett JF; Mustafa A; O'neal L; Mason DJ
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):890-3. PubMed ID: 12440940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei.
    Greenwood BN; Foley TE; Day HE; Burhans D; Brooks L; Campeau S; Fleshner M
    Biol Psychiatry; 2005 Mar; 57(5):559-68. PubMed ID: 15737672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early weaning results in less active behaviour, accompanied by lower 5-HT1A and higher 5-HT2A receptor mRNA expression in specific brain regions of female pigs.
    Sumner BE; D'Eath RB; Farnworth MJ; Robson S; Russell JA; Lawrence AB; Jarvis S
    Psychoneuroendocrinology; 2008 Sep; 33(8):1077-92. PubMed ID: 18653286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy.
    Naumenko VS; Bazovkina DV; Kondaurova EM; Zubkov EA; Kulikov AV
    Genes Brain Behav; 2010 Jul; 9(5):519-24. PubMed ID: 20345894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of serotonin receptors in bone.
    Westbroek I; van der Plas A; de Rooij KE; Klein-Nulend J; Nijweide PJ
    J Biol Chem; 2001 Aug; 276(31):28961-8. PubMed ID: 11387323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.
    Gould GG; Hensler JG; Burke TF; Benno RH; Onaivi ES; Daws LC
    J Neurochem; 2011 Jan; 116(2):291-303. PubMed ID: 21070242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible modulation of process extension by N-methyl-D-aspartate receptor expressed in osteocytic MLO-Y4 cells.
    Fujita H; Hinoi E; Nakatani E; Yamamoto T; Takarada T; Yoneda Y
    J Pharmacol Sci; 2012; 119(1):112-6. PubMed ID: 22641131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.